News
Through tireless work and reinvesting profits back into our company, we developed new products and earned recognition and praise from the industry. As we look to the future, we aim to continue pushing the boundaries of innovation and excellence in our industry, with the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
You are here: Home / News / 2024
end TB.png
END TB: Screening and Triage for TB using Computer-Aided Detection (CAD) Technology

In WHO consolidated guidelines on tuberculosis 2021, Computer-aided detection (CAD) is being recommended for the first time as an alternative to human interpretation of digital chest X-ray (CXR) for TB screening and triage in individuals aged 15 years or older. CAD technology involves using computer algorithms to assist in the interpretation of medical imaging, such as chest X-rays, for TB detection. Evaluations indicates that CAD software programmes are accurate and their performance compares well with human interpretation of CXR for detection of TB disease. CAD systems can analyze large volumes of images rapidly, facilitating mass screening and timely diagnosis and intervention. Moreover, CAD technology can reduce reliance on highly trained medical personnel for interpretation, has the potential to standardize interpretation, reducing intra- and inter-reader variability.

READ MORE
03/ 24 / 2024
图片2.png
IGF-1 (Insulin-like Growth Factor 1) Test

What is an IGF-1 test?This test measures the amount of IGF-1 (insulin-like growth factor 1) in your blood. IGF-1 is a hormone that manages the effects of growth hormone (GH) in your body. Together, IGF-1 and GH promote normal growth of bones and tissues. GH levels in the blood fluctuate throughout the day depending on your diet and activity levels. But IGF-1 levels remain stable. So, an IGF-1 test is a useful way to find out if your body is making a normal amount of GH.

READ MORE
02/ 14 / 2024
微信截图_20231207181802.png
What We Should Know About TORCH Infections

TORCH is an acronym for a group of four infectious diseases that may cause illness in pregnant women and may cause birth defects in their newborns depending on the stage of pregnancy when the mother is infected. The tests are a screen for the presence of any of the antibodies to these infections. Confirmation of an active infection may require more specific tests.

READ MORE
01/ 08 / 2024

Who We Are

With the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
Contact Us
Address: 291 Brighton Road South Croydon United Kingdom Cr2 6Eq    E-mail: info@medlere.com    Tel.: +447565748991
The content on the Medlere website may showcase some of our forthcoming care offerings, which are currently under development. Please note that these offerings are subject to completion of the development process and may require regulatory authorization, clearance, or approval before they can be made available for commercial use.
@​2023 Medlere Limited. All Rights Reserved.